Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The γ-hydroxybutyrate receptor (GHBR) is an excitatory G protein-coupled receptor that binds the neurotransmitter γ-hydroxybutyric acid (GHB). It plays a role in neuronal energy homeostasis and sleep–wake regulation, and its activation modulates glutamate, dopamine, and serotonin systems. At low concentrations of GHB, it acts as an agonist, stimulating dopamine release. At higher concentrations, it also acts as a weak agonist at inhibitory metabotropic GABA_B receptors. This dual action explains both sedative and stimulatory properties observed with different doses of exogenous or pharmacological administration of GHB. The GHBR is densely expressed throughout various regions of the brain including the hippocampus, frontal cortex, and cerebellum.
Agonist or antagonist at GHB receptors, influencing downstream dopamine, glutamate and serotonin release.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on γ-Hydroxybutyrate Receptor (GHBR).